Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Arm Study of the Combination of Biweekly Avastin and Docetaxel as the First Line Treatment for Patients With Metastatic Breast Cancer

NCT00979641 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.

NCT NCT00979641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00979641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Arm Study of the Combination of Biweekly Avastin and Docetaxel as the First Line Treatment for Patients With Metastatic Breast Cancer
Lead sponsor
Tampere University Hospital
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2009
Completion date
December 31, 2014
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms